NFKB1 and acute respiratory distress syndrome: SN50 dose-dependently attenuates the abnormalities of alveolar coagulation and fibrinolysis via inhibition of NF-κB p65 translocation from cytoplasm to nucleus and p65 DNA binding activities in LPS-induced ARDS.